Av. Komleva et al., PHOSPHOLIPIDS AND GLYCOSPHINGOLIPIDS IN CULTURED SKIN FIBROBLASTS FROM PATIENTS WITH PROGRESSIVE SYSTEMIC-SCLEROSIS (SCLERODERMA), Clinical and experimental rheumatology, 13(5), 1995, pp. 581-588
Objective. A comparative investigation of glycosphingolipids and phosp
holipids of cultured skin fibroblasts from healthy donors and patients
with progressive systemic sclerosis (SSc) was performed. Methods. Cul
ture techniques, qualitative and quantitative lipid analyses, determin
ation of neuraminidase activity, and immunofluorescence microscopy wer
e used. Results. The quantitative content of individual phospholipids
in the fibroblasts of SSc patients (PF) was equally elevated, on the a
verage 2.8 times in comparison with the fibroblasts of healthy donors
(DF). The total content of neutral glycosphingolipids was slightly ele
vated only because of a 1.5-fold increase of monoglucosylceramide in P
F. A decrease in the amount of the gangliosides GM3 and GM1 and the ab
sence of the disialogangliosides in PF in comparison with DF, were dem
onstrated. Immunofluorescent assay also showed a decrease of gangliosi
de epitopes on the cellular surface of PF in comparison with DF. The G
M3-neuraminidase activity of PF homogenates was increased two-fold in
comparison to normal values. Conclusions. These results are discussed
in connection with abnormalities in membrane receptor functions, alter
ations in the cell phenotype and AMP-cyclase system activity, as well
as hyperproduction of extracellular matrix proteins by PF.